"Last hope": Eager Germans are prepared to pay for weight-loss drug

Strong U.S. demand eases pressure on Novo to show weight-loss drug's health benefits

Biotech firms target weight-loss drugs without Wegovy's side-effects

Hold the Ozempic before surgery, US doctors say

Analysis-Weight loss drug candidates multiply, spurring hopes of better outcomes, lower costs

Novo Nordisk says obesity pill leads to 15% weight loss; availability "to be determined"

Experimental Lilly pill, Mounjaro both lead to 15% weight loss in clinical trials

Britain to explore wider access to weight-loss drugs in two-year pilot

Weight-loss drug pioneers aim to jump on Wegovy bandwagon

Novo Nordisk: trial data of oral weight-loss drug comparable to Wegovy

Obesity drug brings heart health benefit alongside weight loss - study

Exclusive-Wegovy, other weight loss drugs ‘no silver bullet’, says WHO amid obesity review